Results 161 to 170 of about 17,466 (191)

SIRT2-mediated deacetylation activates USP22 catalytic function for PD-L1 protein stabilization and tumor immune escape. [PDF]

J Clin Invest
Li N, Gao Q, Jia H, Xue G, Zhou Y, Wang S, Ma S, Hu B, Zhao Z, Su C, Liu Y, Xi W, Li Z, Zhang DD, Chu P, Sun Z, Fang D.   +16 more
europepmc   +1 more source

USP8 promotes the progression of sepsis-induced acute lung injury by interacting with the USP24 to suppress PGC-1α deubiquitination and expression. [PDF]

Redox Biol
Lai W, Xing X, Ahan S, Liu Y, Jiang W.
europepmc   +1 more source

Yes-Associated Protein Drives Helicobacter pylori-Induced Metaplastic Changes in Gastric Epithelium. [PDF]

Cell Mol Gastroenterol Hepatol
Yu BM, Lee SD, Hwang BR, Jeong H, Kim J, Hwang S, Noh M, Nam KT, Lee YC.   +8 more
europepmc   +1 more source

The deubiquitinase CYLD inhibits thrombin-induced p38 MAPK-p65 NF-κB signaling and inflammatory cytokine production to suppress triple-negative breast cancer progression. [PDF]

J Biol Chem
Pimentel JM, Bosompra O, Trejo J.
europepmc   +1 more source

Editorial commentary on the special section on cancer research. [PDF]

J Biomed Res
Board E.
europepmc   +1 more source

Fine-Tuning Protein Fate: Mechanisms of E1, E2, and E3 Enzymes and Deubiquitinases in Cell Signaling. [PDF]

Int J Mol Sci
Kim Y, Kim EK, Jang HH.
europepmc   +1 more source

ZRANB1 depletion inhibits neuroblastoma progression by destabilizing MYCN through EZH2-mediated deubiquitination. [PDF]

Cell Biol Toxicol
Wang Z, Cheng L, Li G, Cheng H.
europepmc   +1 more source

OTU deubiquitinases as immune-circuit editors: from human immunopathology to therapeutic prioritization. [PDF]

Front Immunol
Guo Y, Song Y, Wang C, Xiong R, Bao X, Lu S, Wu W, Wang X, Liao J, Bao Y, Qu L, Rao Z, Han Q.   +12 more
europepmc   +1 more source